渐进性肌性:对诊断,表型和治疗方面的进展进行全面审查
Vincent Zimmern1, Berge Minassian1
1Division of Child Neurology, University of Texas Southwestern, Dallas, TX 75390, USA.
Genes
|February 24, 2024
概括
渐进性肌性 (PME) 是一种罕见的,严重的神经疾病. 最近的研究已经显著提升了对 PME 的理解和治疗,为改善患者结果提供了希望.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 罕见疾病 罕见疾病
背景情况:
- 渐进性肌性 (PME) 包含一组罕见的,衰弱的神经系统疾病,其特征是肌性和逐渐恶化的发作.
- 尽管个体罕见,但PME占专门中心管理的复杂病例的很大一部分.
研究的目的:
- 对过去十年的英语出版物进行范围审查.
- 综合了所有PME亚型的诊断,表型和治疗方面的最新进展.
- 确定关键的经验教训和有前途的未来研究方向.
主要方法:
- 覆盖范围审查方法.
- 系统地搜索过去10年出版的英语文学.
- 专注于所有小型企业的诊断,表型和治疗方面的进步.
主要成果:
- 在过去的十年中,在了解 PME 病理生理学,诊断和预后方面取得了重大进展.
- 对于选择的 PME 疾病,已经确定了治疗方面的进展.
- 介绍了诊断标准,临床特征和治疗选择的全面概述.
结论:
- 在过去的十年中,对 PME 产生了重要的见解,改善了诊断准确性和治疗策略.
- 持续的研究对于解决管理这些复杂的渐进性神经疾病的剩余挑战至关重要.
- 未来的研究应该专注于将最近的发现转化为所有 PME 患者的有效临床干预措施.
关键词:
拉福拉病是拉福拉的疾病.北海中小企业 北海中小企业伦德堡病 - - 伦德堡病 - - 伦德堡病.酸胺酶缺乏症 酸胺酶缺乏肌性,带有破碎的红色纤维.神经神经元的seroid lipofuscinoses可能会发生.渐进的肌性发症 进展性肌性发症治疗疗法治疗疗法治疗疗法更多相关视频
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
2.6K
06:04Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
839
相关概念视频
Seizures: Classification
349
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
349
Arteries of the Lower Limbs
189
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
189
Myasthenia Gravis: Diagnostic Tests
840
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
840
Antiepileptic Drugs: Glutamate Antagonists
355
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
355
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
